FR2450M - Nouvelles pyrimidines. - Google Patents

Nouvelles pyrimidines.

Info

Publication number
FR2450M
FR2450M FR928687A FR928687A FR2450M FR 2450 M FR2450 M FR 2450M FR 928687 A FR928687 A FR 928687A FR 928687 A FR928687 A FR 928687A FR 2450 M FR2450 M FR 2450M
Authority
FR
France
Prior art keywords
new pyrimidines
pyrimidines
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR928687A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of FR2450M publication Critical patent/FR2450M/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR928687A 1962-03-22 1963-03-20 Nouvelles pyrimidines. Active FR2450M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET21813A DE1197466B (de) 1962-03-22 1962-03-22 Verfahren zur Herstellung von neuen 5, 6, 7, 8-Tetrahydropyrido-[4, 3-d]pyrimidinen

Publications (1)

Publication Number Publication Date
FR2450M true FR2450M (fr) 1964-04-06

Family

ID=7550280

Family Applications (1)

Application Number Title Priority Date Filing Date
FR928687A Active FR2450M (fr) 1962-03-22 1963-03-20 Nouvelles pyrimidines.

Country Status (5)

Country Link
US (1) US3248395A (fr)
CH (2) CH462186A (fr)
DE (1) DE1197466B (fr)
FR (1) FR2450M (fr)
GB (1) GB1033384A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005014558A1 (fr) * 2003-08-05 2005-02-17 Vertex Pharmaceuticals Incorporated Composes de pyramidine condenses utilises comme inhibiteurs de canaux ioniques potentiel-dependants
US8828990B2 (en) 2009-11-12 2014-09-09 Genentech, Inc. N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725405A (en) * 1970-06-18 1973-04-03 American Home Prod 2,4,7-TRISUBSTITUTED-{8 PYRIDO 2,3-d{9 PYRIMIDINE-6-CARBOXAMIDES
US3939268A (en) * 1971-04-10 1976-02-17 Boehringer Ingelheim Gmbh 2,4-Diamino substituted pyridol(3,2-d)pyrimidine as antithrombotic agents
JPS5130077B2 (fr) * 1971-12-28 1976-08-30
US4085102A (en) * 1974-11-25 1978-04-18 E. R. Squibb & Sons, Inc. 2-Amino-8-arylideno-3,4,5,6,7,8-hexahydro-4-arlypyrido[4,3-d]pyrimidines
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US5059602A (en) * 1990-08-27 1991-10-22 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
EP0974129B1 (fr) * 1996-09-04 2006-08-16 Intertrust Technologies Corp. Systeme d'assistance infrastructurelle administrative, procedes et techniques surs concernant le commerce et les transactions electroniques, commande et automatisation des processus commerciaux, calcul reparti et gestion des redevances
US7105667B2 (en) * 2001-05-01 2006-09-12 Bristol-Myers Squibb Co. Fused heterocyclic compounds and use thereof
WO2002088079A2 (fr) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Inhibiteurs doubles de pde 7 et pde 4
EP1552842A1 (fr) * 2002-06-07 2005-07-13 Kyowa Hakko Kogyo Co., Ltd. Derives bicycliques de pyrimidine
AU2004283196B2 (en) * 2003-09-17 2011-08-25 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
US7745451B2 (en) * 2005-05-04 2010-06-29 Renovis, Inc. Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
CN101983191B (zh) 2008-02-01 2013-11-20 武田药品工业株式会社 作为hsp90抑制剂的肟衍生物
EP2318377B1 (fr) * 2008-07-31 2013-08-21 Genentech, Inc. Composés de pyrimidine, compositions et procédés d'utilisation
WO2010120991A1 (fr) * 2009-04-17 2010-10-21 Wyeth Llc Composés de 5,6,7,8-tétrahydropyrido[4,3-d]pyrimidine, leur utilisation en tant qu'inhibiteurs de kinase mtor, pi3, et hsmg-1, et leurs synthèses
CA2766151A1 (fr) * 2009-06-24 2010-12-29 Genentech, Inc. Composes pyrimidine fusionnes a oxo-heterocycles, compositions et procedes d'utilisation
EP2467382B1 (fr) * 2009-08-17 2014-06-25 Merck Sharp & Dohme Corp. Amino-tétrahydro-pyridopyrimidine inhibiteurs de pde10
CN102711766B (zh) * 2009-11-12 2014-06-04 霍夫曼-拉罗奇有限公司 N-9-取代的嘌呤化合物、组合物和使用方法
UA112517C2 (uk) 2010-07-06 2016-09-26 Новартіс Аг Тетрагідропіридопіримідинові похідні

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2697710A (en) * 1953-01-02 1954-12-21 Burroughs Wellcome Co Pyrido (2,3-d) pyrimidines and method of preparing same
US2926166A (en) * 1954-01-04 1960-02-23 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making
US2802826A (en) * 1955-07-13 1957-08-13 Hoffmann La Roche Octahydro-pyrido [4, 3-d] pyrimidine compounds
US2890152A (en) * 1956-11-29 1959-06-09 Schering Corp Topical anti-inflammatory compositions
US2994640A (en) * 1957-02-22 1961-08-01 Byk Gulden Lomberg Chem Fab Anti-inflammatory therapy with purine molecular compounds
DE1110649B (de) * 1957-11-22 1961-07-13 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-pyrazolo[3, 4-d]pyrimidinen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005014558A1 (fr) * 2003-08-05 2005-02-17 Vertex Pharmaceuticals Incorporated Composes de pyramidine condenses utilises comme inhibiteurs de canaux ioniques potentiel-dependants
US7968545B2 (en) 2003-08-05 2011-06-28 Vertex Pharmaceuticals Inc. Compositions useful as inhibitors of voltage-gated ion channels
JP2011207914A (ja) * 2003-08-05 2011-10-20 Vertex Pharmaceuticals Inc 電位依存型イオンチャネルの阻害剤としての縮合ピリミジン化合物
JP4808156B2 (ja) * 2003-08-05 2011-11-02 バーテックス ファーマシューティカルズ インコーポレイテッド 電位依存型イオンチャネルの阻害剤としての縮合ピリミジン化合物
US8828990B2 (en) 2009-11-12 2014-09-09 Genentech, Inc. N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use

Also Published As

Publication number Publication date
US3248395A (en) 1966-04-26
GB1033384A (en) 1966-06-22
CH462186A (de) 1968-09-15
CH437327A (de) 1967-06-15
DE1197466B (de) 1965-07-29

Similar Documents

Publication Publication Date Title
FR2973M (fr) Alpha-aminocétone.
FR2450M (fr) Nouvelles pyrimidines.
FR3846M (fr) Nouvelles 4-amino-pipéridines.
FR2770M (fr) Nouvelles dihalogéno-amino-benzylamines.
FR3239M (fr) Nouvelles amines substituées.
DK112125B (da) Falstagsten.
DK105974C (da) Lastpallemagasin.
DK106882C (da) Tagafdækning.
NL143659B (nl) Fluidum-en-afsluiting.
FR3110M (fr) Nouvelles benzamides.
FR3046M (fr) Nouvelles phényléthanolamines.
FR2592M (fr) Phénylbicyclononanes substitués.
FR3546M (fr) Azabenzocycloalcane-n-carboxamidines.
OA01221A (fr) Polythioformaldéhydes.
FR3088M (fr) 2-oxo-tétrahydroquinoléines substituées.
FR3325M (fr) Nouvelles 2-alcoyl-4-pyridine-aldéhyde-thiosemicarbazones.
BE642025A (fr) Nouvelles indolylalcoylguanidines.
DK103099C (da) Plov.
FR2894M (fr) Phénylalcanolamine.
FR2503M (fr) Nouvelles phénylhétéroalcoylamines.
BE617318A (nl) Bouwwerk.
FR2953M (fr) Nouvelles pénicillines.
BE605579A (fr) Nouvelles sulfonylurées.
GR23071B (el) Ειδικη κεραμος.
FR2792M (fr) Nouvelles tétrahydro-dibenzazocines substituées.